Immunoinflammatory Background of Neuronal Damage in Stroke
Conflicts of Interest
References
- Kimura, K.; Kazui, S.; Minematsu, K.; Yamaguchi, T.; Japan Multicenter Stroke Investigator’s Collaboration. Analysis of 16,922 patients with acute ischaemic stroke and transient ischaemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc. Dis. 2004, 18, 47–56. [Google Scholar] [CrossRef] [PubMed]
- Furie, K.L.; Homma, S.; Kistler, J.P. Cardiac diseases. In Stroke: Pathophysiology, Diagnosis, and Management, 4th ed.; Churchill Livingstone: New York, NY, USA, 2004; pp. 747–759. [Google Scholar]
- Ekdahl, C.T.; Kokaia, Z.; Lindvall, O. Brain inflam-mation and adult neurogenesis: The dual role of micro-glia. Neuroscience 2008, 158, 1021–1029. [Google Scholar] [CrossRef] [PubMed]
- Welsh, P.; Lowe, G.D.; Chalmers, J.; Campbell, D.J.; Rumley, A.; Neal, B.C.; MacMahon, S.W.; Woodward, M. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008, 39, 2226–2230. [Google Scholar] [CrossRef] [PubMed]
- Licata, G.; Tuttolomondo, A.; Corrao, S.; Raimondo, D.D.; Fernandez, P.; Carusoi, C.; Avellone, G.; Pinto, A. Inflamnoinflammatory activation during the acute phase of lacunar and non-lacunar ischaemic stroke: Association with time of onset and diabetic state. Int. J. Immunopathol. Pharmacol. 2006, 19, 639–646. [Google Scholar] [CrossRef] [PubMed]
- Castellanos, M.; Castillo, J.; García, M.; Leira, R.; Serena, J.; Chamorro, A.; Dávalos, A. Inflammation-mediated damage in progressing lacunar in-farctions. A potential therapeutic target. Stroke 2002, 33, 982–987. [Google Scholar] [CrossRef] [PubMed]
- Licata, G.; Tuttolomondo, A.; Di Raimondo, D.; Corrao, S.; Di Sciacca, R.; Pinto, A. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb. Haemost. 2009, 101, 929–937. [Google Scholar] [PubMed]
- Carandina, A.; Lazzeri, G.; Villa, D.; Di Fonzo, A.; Bonato, S.; Montano, N.; Tobaldini, E. Targeting the Autonomic Nervous System for Risk Stratification, Outcome Prediction and Neuromodulation in Ischemic Stroke. Int. J. Mol. Sci. 2021, 22, 2357. [Google Scholar] [CrossRef] [PubMed]
- De Raedt, S.; De Vos, A.; De Keyser, J. Autonomic dysfunction in acute ischemic stroke: An underexplored therapeutic area? J. Neurol. Sci. 2015, 348, 24–34. [Google Scholar] [CrossRef]
- Tuttolomondo, A.; Puleo, M.G.; Velardo, M.C.; Corpora, F.; Daidone, M.; Pinto, A. Molecular Biology of Atherosclerotic Ischemic Strokes. Int. J. Mol. Sci. 2020, 21, 9372. [Google Scholar] [CrossRef]
- Di Raimondo, D.; Rizzo, G.; Musiari, G.; Tuttolomondo, A.; Pinto, A. Role of Regular Physical Activity in Neuroprotection against Acute Ischemia. Int. J. Mol. Sci. 2020, 21, 9086. [Google Scholar] [CrossRef] [PubMed]
- Nikolic, D.; Jankovic, M.; Petrovic, B.; Novakovic, I. Genetic Aspects of Inflammation and Immune Response in Stroke. Int. J. Mol. Sci. 2020, 21, 7409. [Google Scholar] [CrossRef] [PubMed]
- Maida, C.D.; Norrito, R.L.; Daidone, M.; Tuttolomondo, A.; Pinto, A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int. J. Mol. Sci. 2020, 21, 6454. [Google Scholar] [CrossRef] [PubMed]
- Tuttolomondo, A.; Di Raimondo, D.; Pecoraro, R.; Maida, C.; Arnao, V.; Della Corte, V.; Simonetta, I.; Corpora, F.; Di Bona, D.; Maugeri, R.; et al. Early High-dosage Atorvastatin Treatment Improved Serum Immune-inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial. Medicine 2016, 95, e3186. [Google Scholar] [CrossRef] [PubMed]
- Tuttolomondo, A.; Casuccio, A.; Guercio, G.; Maida, C.; Del Cuore, A.; Di Raimondo, D.; Simonetta, I.; Di Bona, D.; Pecoraro, R.; Della Corte, V.; et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc. Diabetol. 2017, 16, 2. [Google Scholar] [CrossRef] [PubMed]
- Petta, S.; Marrone, O.; Torres, D.; Buttacavoli, M.; Cammà, C.; Di Marco, V.; Licata, A.; Lo Bue, A.; Parrinello, G.; Pinto, A.; et al. Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE 2015, 10, e0142210. [Google Scholar] [CrossRef]
- Di Bona, D.; Scafidi, V.; Plaia, A.; Colomba, C.; Nuzzo, D.; Occhino, C.; Tuttolomondo, A.; Giammanco, G.; De Grazia, S.; Montalto, G.; et al. HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection. J. Infect. Dis. 2014, 210, 1083–1089. [Google Scholar] [CrossRef]
- Tuttolomondo, A.; Casuccio, A.; Della Corte, V.; Maida, C.; Pecoraro, R.; Di Raimondo, D.; Vassallo, V.; Simonetta, I.; Arnao, V.; Pinto, A. Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke: Relationship with TOAST subtype. Atherosclerosis 2017, 256, 94–99. [Google Scholar] [CrossRef]
- Tuttolomondo, A.; Petta, S.; Casuccio, A.; Maida, C.; Corte, V.D.; Daidone, M.; Di Raimondo, D.; Pecoraro, R.; Fonte, R.; Cirrincione, A.; et al. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): A case control study. Cardiovasc. Diabetol. 2018, 17, 28. [Google Scholar] [CrossRef]
- Di Raimondo, D.; Tuttolomondo, A.; Musiari, G.; Schimmenti, C.; D’Angelo, A.; Pinto, A. Are the Myokines the Mediators of Physical Activity-Induced Health Benefits? Curr. Pharm. Des. 2016, 22, 3622–3647. [Google Scholar] [CrossRef]
- Petta, S.; Tuttolomondo, A.; Gagliardo, C.; Zafonte, R.; Brancatelli, G.; Cabibi, D.; Cammà, C.; Di Marco, V.; Galvano, L.; La Tona, G.; et al. The Presence of White Matter Lesions Is Associated with the Fibrosis Severity of Nonalcoholic Fatty Liver Disease. Medicine 2016, 95, e3446. [Google Scholar] [CrossRef]
- Tuttolomondo, A.; Di Raimondo, D.; Pecoraro, R.; Casuccio, A.; Di Bona, D.; Aiello, A.; Accardi, G.; Arnao, V.; Clemente, G.; Corte, V.D.; et al. KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke. J. Neuroinflamm. 2019, 16, 88. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tuttolomondo, A. Immunoinflammatory Background of Neuronal Damage in Stroke. Int. J. Mol. Sci. 2023, 24, 8619. https://doi.org/10.3390/ijms24108619
Tuttolomondo A. Immunoinflammatory Background of Neuronal Damage in Stroke. International Journal of Molecular Sciences. 2023; 24(10):8619. https://doi.org/10.3390/ijms24108619
Chicago/Turabian StyleTuttolomondo, Antonino. 2023. "Immunoinflammatory Background of Neuronal Damage in Stroke" International Journal of Molecular Sciences 24, no. 10: 8619. https://doi.org/10.3390/ijms24108619